The TRuST study concluded that quantitative G6PD testing followed by P vivax radical cure was highly feasible in the Brazilian Amazon with no concerning risk for acute haemolytic anaemia.8 The gene discussed is G6PD; the disease is non-autoimmune hemolytic anemia.